APA-viite

Sawada, Y., Yoshikawa, T., Ofuji, K., Yoshimura, M., Tsuchiya, N., Takahashi, M., . . . Nakatsura, T. (2016). Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients. Oncoimmunology.

Chicago-tyylinen lähdeviittaus

Sawada, Yu, et al. "Phase II Study of the GPC3-derived Peptide Vaccine As an Adjuvant Therapy for Hepatocellular Carcinoma Patients." Oncoimmunology 2016.

MLA-viite

Sawada, Yu, et al. "Phase II Study of the GPC3-derived Peptide Vaccine As an Adjuvant Therapy for Hepatocellular Carcinoma Patients." Oncoimmunology 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.